Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director | June 15, 2026 | June 16, 2026 |
| Forbright, Inc.FRBT · Entity 5025 | Director | July 16, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,144 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Sale · Disposed 2,596 · Balance 23,144 F1: On June 15, 2026, the Reporting Person sold 2,596 shares of the Issuer's common stock on the open market at a price of $666.31 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 15, 2026, the Reporting Person sold 2,596 shares of the Issuer's common stock on the open market at a price of $666.31 per share.
Forbright, Inc.
Report date July 16, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 20,241 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 220 · Balance 20,241 F1: Represents fully vested deferred restricted stock units ("DRSUs") granted in lieu of the Reporting Person's quarterly cash retainer fee, which will settle in shares following the termination of the Reporting Person's service as a member of the Issuer's board of directors. Each DRSU represents a contingent right to receive one share of Class A common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents fully vested deferred restricted stock units ("DRSUs") granted in lieu of the Reporting Person's quarterly cash retainer fee, which will settle in shares following the termination of the Reporting Person's service as a member of the Issuer's board of directors. Each DRSU represents a contingent right to receive one share of Class A common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2026 Filed Jul 17, 2026 20:21 UTC | Forbright, Inc. FRBT · Entity 5025 | GrantClass A Common Stock | 220 | $18.68 | $4,109.60 |
DisclosureSEC source: 0001925062-26-000012 · wk-form4_1784319677.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,241 F1 · shares: Represents fully vested deferred restricted stock units ("DRSUs") granted in lieu of the Reporting Person's quarterly cash retainer fee, which will settle in shares following the termination of the Reporting Person's service as a member of the Issuer's board of directors. Each DRSU represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,596 | $666.31 | $1,729,740.76 |
DisclosureSEC source: 0001463638-26-000008 · form4-06162026_040605.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,144 F1 · shares: On June 15, 2026, the Reporting Person sold 2,596 shares of the Issuer's common stock on the open market at a price of $666.31 per share. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 189 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001463638-26-000006 · form4-06122026_040613.xml · derivative · entry 4 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,023 Underlying: Common Stock · 189 shares Expires not disclosed F3 · derivative.exercise_date: On June 10, 2026, the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. F3 · derivative.expiration_date: On June 10, 2026, the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001463638-26-000006 · form4-06122026_040613.xml · derivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 834 Underlying: Common Stock · 530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001463638-26-000006 · form4-06122026_040613.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001463638-26-000006 · form4-06122026_040613.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,207 F1 · shares: On June 10, 2026, the Reporting Person made a bona fide gift of 1,000 shares of the Issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:09 UTC | Forbright, Inc. FRBT · Entity 5025 | GrantClass A Common Stock | 6,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269415 · ownership.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,021 F1 · shares: Represents restricted stock units ("RSUs") granted under the Issuer's 2026 Omnibus Incentive Plan. The RSUs will vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a member of the Issuer's board of directors through such vesting date. Each RSU represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 19,000 | $386.70 | $7,347,300.00 |
DisclosureSEC source: 0001463638-26-000004 · form4-01232026_050101.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,207 F1 · shares: On January 21, 2026, the Reporting Person sold 19,000 shares of the Issuer's common stock on the open market at an average price of $386.70 per share. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $35.72 Strike: $35.72 | $178,600.00 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 8 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $37.13 Strike: $37.13 | $185,650.00 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 7 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $45.75 Strike: $45.75 | $457,500.00 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 6 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $40.15 Strike: $40.15 | $401,500.00 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · derivative · entry 5 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 4,427 | $35.72 | $158,132.44 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 4 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 4,405 | $37.13 | $163,557.65 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,534 | $45.75 | $390,430.50 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,713 | $40.15 | $349,826.95 |
DisclosureSEC source: 0001463638-26-000002 · form4-01142026_050103.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 13, 2026, the Reporting Person exercised her stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 22:46 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001463638-25-000007 · form4-12172025_101259.xml · derivative · entry 4 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,364 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 22:46 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001463638-25-000007 · form4-12172025_101259.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. Read SEC document |
| December 14, 2025 Filed Dec 17, 2025 22:46 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001463638-25-000007 · form4-12172025_101259.xml · derivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,114 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. Read SEC document |
| December 14, 2025 Filed Dec 17, 2025 22:46 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 856 | $0.00 | $0.00 |
DisclosureSEC source: 0001463638-25-000007 · form4-12172025_101259.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. Read SEC document |
| October 08, 2025 Filed Oct 8, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 15,000 | $271.96 | $4,079,400.00 |
DisclosureSEC source: 0001463638-25-000005 · form4-10082025_041001.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,428 F1 · shares: On October 8, 2025, the Reporting Person sold 15,000 shares of the Issuer's common stock on the open market at an average price of $271.96 per share. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 22:45 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,000 | $234.56 | $469,120.00 |
DisclosureSEC source: 0001415889-25-020611 · form4-07302025_100716.xml · nonDerivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Cynthia Flanders Charitable Trust GRAT Disclosed balance after: 0 F2 · price: On July 30, 2025, the Cynthia Flanders Charitable Trust GRAT sold 2,000 shares of the Issuer's common stock on the open market at an average price of $234.56 per share. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 22:45 UTC | ARGAN INC AGX · Entity 3828 | OtherCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-020611 · form4-07302025_100716.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Cynthia Flanders Charitable Trust GRAT Disclosed balance after: 2,000 F1 · shares: On July 28, 2025, the Reporting Person transferred 2,000 shares of the Issuer's common stock to the Cynthia Flanders Charitable Trust GRAT. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 22:45 UTC | ARGAN INC AGX · Entity 3828 | OtherCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-020611 · form4-07302025_100716.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,428 F1 · shares: On July 28, 2025, the Reporting Person transferred 2,000 shares of the Issuer's common stock to the Cynthia Flanders Charitable Trust GRAT. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 23:55 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017908 · form4-06202025_110610.xml · derivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,947 Underlying: Common Stock · 530 shares Expires not disclosed F1 · derivative.exercise_date: On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on June 17, 2026. F1 · derivative.expiration_date: On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on June 17, 2026. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 20:30 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 15,000 | $220.47 | $3,307,050.00 |
DisclosureSEC source: 0001415889-25-017536 · form4-06172025_040604.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,428 F1 · shares: On June 12, 2025, the Reporting Person sold 15,000 shares of the Issuer's common stock on the open market at an average price of $220.47 per share. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · derivative · entry 10 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends. F5 · derivative.expiration_date: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · nonDerivative · entry 5 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $41.19 Strike: $41.19 | $411,900.00 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · derivative · entry 9 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 10,000 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $46.35 Strike: $46.35 | $463,500.00 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · derivative · entry 8 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock · Derivative | 10,000 | $71.75 Strike: $71.75 | $717,500.00 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · derivative · entry 7 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,500 Underlying: Common Stock · 10,000 shares Expires 2027-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on January 5, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $71.75 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock · Derivative | 10,000 | $30.44 Strike: $30.44 | $304,400.00 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · derivative · entry 6 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,500 Underlying: Common Stock · 10,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on January 7, 2016 to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,308 | $41.19 | $342,206.52 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · nonDerivative · entry 4 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,096 | $46.35 | $375,249.60 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · nonDerivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 7,053 | $71.75 | $506,052.75 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on January 5, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $71.75 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,749 | $30.44 | $266,319.56 |
DisclosureSEC source: 0001415889-25-016658 · form4-06112025_040607.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 9, 2025, the Reporting Person exercised her stock option awarded on January 7, 2016 to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share, using the net settle method. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 4,092 | $133.64 | $546,854.88 |
DisclosureSEC source: 0001415889-25-009934 · form4-04032025_040403.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,832 F1 · shares: On April 2, 2025, the Reporting Person sold 4,092 shares of the Issuer's common stock on the open market at an average price of $133.64 per share, Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029467 · form4-12162024_041203.xml · derivative · entry 5 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,805 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029467 · form4-12162024_041203.xml · derivative · entry 4 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,638 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 835 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029467 · form4-12162024_041203.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029467 · form4-12162024_041203.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029467 · form4-12162024_041203.xml · derivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,388 Underlying: Common Stock · 388 shares Expires not disclosed F3 · derivative.exercise_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. F3 · derivative.expiration_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 20:05 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $96.39 | $481,944.00 |
DisclosureSEC source: 0001415889-24-024038 · form4-09272024_080953.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,332 F1 · shares: On September 25, 2024, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average share price of $96.388850. Read SEC document |
| June 17, 2024 Filed Jun 17, 2024 21:21 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $31.82 | $0.00 |
DisclosureSEC source: 0001415889-24-017250 · form4-06172024_090657.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,500 Underlying: Common Stock · 10,000 shares Expires 2024-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 17, 2024, the Reporting Person exercised her stock option awarded on December 11, 2014 to purchase 10,000 shares of the Issuer's common stock at a price of $31.82 per share, using the net settle method. Read SEC document |
| June 17, 2024 Filed Jun 17, 2024 21:21 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,832 | $31.82 | $185,574.24 |
DisclosureSEC source: 0001415889-24-017250 · form4-06172024_090657.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 17, 2024, the Reporting Person exercised her stock option awarded on December 11, 2014 to purchase 10,000 shares of the Issuer's common stock at a price of $31.82 per share, using the net settle method. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:23 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016626 · form4-12182023_101224.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,500 shares Expires 2026-12-14 F2 · shares: On December 14, 2023, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 2,500 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 12/14/2024. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:23 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001415889-23-016626 · form4-12182023_101224.xml · derivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,500 Underlying: Common Stock · 1,500 shares Expires 2033-12-14 F1 · shares: On December 14, 2023, the Reporting Person received 10-year options to purchase 1,500 shares of the Issuer's common stock with an exercise price of $43.70 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2024. Read SEC document |
| October 12, 2023 Filed Oct 12, 2023 22:04 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 1,500 | $46.53 | $69,795.00 |
DisclosureSEC source: 0001415889-23-014183 · form4-10122023_101044.xml · nonDerivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 F2 · shares: On October 12, 2023, the Reporting Person purchased 1,500 shares of the Issuer's Common Stock on the open market at a price of $46.53 per share. Read SEC document |
| October 05, 2023 Filed Oct 12, 2023 22:04 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock · Derivative | 7,000 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001415889-23-014183 · form4-10122023_101044.xml · derivative · entry 4 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 7,000 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On October 5, 2023, the Reporting Person exercised the remaining portion of her stock option received on December 17, 2013 to purchase 7,000 shares of the Issuer's Common Stock at a price of $26.88 per share; then sold the shares on the open market at a price of $46.00 per share. Read SEC document |
| October 05, 2023 Filed Oct 12, 2023 22:04 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 7,000 | $46.00 | $322,000.00 |
DisclosureSEC source: 0001415889-23-014183 · form4-10122023_101044.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · shares: On October 5, 2023, the Reporting Person exercised the remaining portion of her stock option received on December 17, 2013 to purchase 7,000 shares of the Issuer's Common Stock at a price of $26.88 per share; then sold the shares on the open market at a price of $46.00 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.